Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.455 1 day ( 0 % )
Last Price $50.62 1.71 %
High/ Low $49.46 - $51.85 1.11%
Chg 7 Days -3.43 % $52.42 $50.62
Chg 30 Days -12.83 % $58.07 $50.62
Chg 12 mos 16.50 % $43.45 $50.62
Trend - 3 mos -24.59 % Width: 24.43 %
Trend - 12 mos 78.56 % Width: 57.76 %
Pred. range - 3 mos $37.01 - $46.06 -26.88 % - -9.01 %
Pred. range - 12 mos $89.11 - $140.59 76.05 % - 177.73 %
Short MA avg 3 mos Sell May 09, 2024 - 4 days
Long MA avg 3 mos Sell Mar 28, 2024 - 33 days
Short/Long MA avg 3 mos Sell Apr 03, 2024 - 30 days
Short MA avg 12 mos Sell Mar 27, 2024 - 34 days
Long MA avg 12 mos Sell Apr 09, 2024 - 26 days
Short/Long MA avg 12 mos Sell Apr 23, 2024 - 16 days
Pivot Short Sell May 10, 2024 - 3 days
Bollinger Buy Apr 08, 2024 - 27 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Arcellx, Inc.

Arcellx. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent Sp... ACLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT